NSP Q2 Deep Dive: Margin Recovery Progress and Strategic HRScale Launch

July 30, 2026 at 01:31 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NSP Cover Image

HR outsourcing provider Insperity (NYSE: NSP) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.7% year on year to $1.69 billion. Its non-GAAP profit of $0.34 per share was 6.9% above analysts’ consensus estimates.

Is now the time to buy NSP? Find out in our full research report (it’s free for active Edge members).

Insperity (NSP) Q2 CY2026 Highlights:

Revenue: $1.69 billion vs analyst estimates of $1.67 billion (1.7% year-on-year growth, 0.7% beat)
Adjusted EPS: $0.34 vs analyst estimates of $0.32 (6.9% beat)
Adjusted EBITDA: $36 million vs analyst estimates of $34.26 million (2.1% margin, 5.1% beat)
Management raised its full-year Adjusted EPS guidance to $2.16 at the midpoint, a 2.6% increase
EBITDA guidance for the full year is $205 million at the midpoint, above analyst estimates of $193.9 million
Operating Margin: 0.4%, in line with the same quarter last year
Market Capitalization: $2.03 billion

StockStory’s Take

Insperity’s second quarter reflected steady progress on its margin recovery initiatives, with revenue and non-GAAP profit both surpassing Wall Street expectations. Management pointed to disciplined cost controls and improving benefit cost trends as central factors, highlighting that gross profit per worksite employee was slightly above internal forecasts. CEO Paul Sarvadi emphasized that the company’s “new agreement with UnitedHealthcare, benefit plan design changes, and strategic pricing” delivered the expected margin improvement, despite continued softness in worksite employee growth and cautious client sentiment among small- and medium-sized businesses.

Looking ahead, Insperity’s updated full-year outlook is built on continued margin recovery efforts and a measured ramp-up of its new HRScale offering. Management expects HRScale to serve as a growth catalyst, particularly in the mid-market segment, and believes the product’s combination of technology and HR services will help address client retention challenges. CFO Jim Allison cautioned that macroeconomic uncertainty and higher attrition rates may continue to weigh on unit growth, but stated, “We are forecasting some continuing improvement as we continue executing the plan throughout 2026.”

Key Insights from Management’s Remarks

Management attributed the quarter’s results to improved cost discipline, benefit cost management, and early success in rolling out HRScale, despite headwinds in client sales and retention.

Margin recovery plan progress: Gross profit per worksite employee improved due to lower benefit costs, favorable client mix, and pricing adjustments, with management noting these actions are on track to deliver a full recovery by 2027.
Worksite employee growth softness: Average paid worksite employee count declined, as efforts to improve margin resulted in higher attrition and lower new client sales, particularly impacting smaller business segments.
HRScale rollout as growth lever: The HRScale platform, combining Insperity’s services with Workday technology, was launched with initial beta clients onboarded. Management sees HRScale as a solution to client churn among larger accounts and expects nearly 6,000 worksite employees to be added via this platform in the next six months.
Benefit cost containment: The new UnitedHealthcare contract and plan design changes contributed to a lower-than-expected increase in benefit costs, with the company noting that most of the positive impact will be realized in the latter part of the year due to changes in claims reimbursement patterns.
Macroeconomic challenges: Management’s client survey revealed increased caution among small- and medium-sized businesses, with more than half expecting a negative economic impact in 2026. CEO Sarvadi said sentiment was “quite dramatic,” impacting both sales and retention, but noted that retained clients are more profitable, supporting margin goals.

Drivers of Future Performance

Insperity’s forward guidance reflects ongoing focus on margin recovery, operational efficiency, and scaling the HRScale platform amid persistent macroeconomic headwinds.

HRScale expansion and adoption: Management expects the continued rollout of HRScale to drive future client wins, especially in the mid-market, by offering a lower-risk, integrated HR solution. Early feedback suggests the product addresses prior retention issues among growing clients seeking advanced technology.
Margin stability from client mix: The current focus on retaining more profitable clients and disciplined pricing is forecast to offset lower worksite employee volumes, with a positive impact on both gross profit per employee and overall margins. Management believes the profitability of terminating clients remains below that of retained clients, supporting ongoing margin recovery.
Macroeconomic and sentiment risks: The company remains cautious regarding small business hiring and retention, as internal surveys and external data point to increased economic uncertainty, inflation concerns, and sensitivity to capital costs. Management acknowledged these factors could limit unit growth, though operational improvements are intended to mitigate their impact.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will be watching (1) the pace of HRScale client adoption and onboarding, (2) the ability of benefit cost containment and client mix improvements to sustain margin recovery, and (3) signs of stabilization or improvement in small- and medium-sized business hiring trends. The impact of macroeconomic sentiment on both unit growth and client retention will also be a critical area of focus.

Insperity currently trades at $53.68, in line with $53.18 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	284.02	+12.44 (4.58%)
AAPL	303.42	-5.49 (-1.78%)
AMD	484.64	+8.49 (1.78%)
BAC	62.48	+0.53 (0.86%)
GOOG	372.47	+15.82 (4.44%)
META	590.24	+33.53 (6.02%)
MSFT	487.65	+22.93 (4.93%)
NVDA	206.64	+5.89 (2.93%)
ORCL	141.85	+11.98 (9.22%)
TSLA	322.08	+10.87 (3.49%)

Get intelligentvalue.com

intelligentvalue.com

Safe & Secure

Fast Transfer

Flexible Payments